Therapeutic Angiogenesis by Gene Therapy for Critical Limb Ischemia: Choice of Biological Agent

Publisher： Bentham Science Publishers

E-ISSN： 1875-6115|14|1|32-39

ISSN： 1871-5222

Source： Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol.14, Iss.1, 2014-04, pp. : 32-39

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Angiogenesis for Limb Ischemia Using Angiogenic Growth Factors and Carriers

By  

Current Tissue Engineering, Vol. 4, Iss. 1, 2015-04 ,pp. : 57-63

Bentham Science Publishers

Access to resources Recommend Favorite

Non-Invasive Treatment of Critical Limb Ischemia

By  

Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 4, Iss. 3, 2004-09 ,pp. : 241-247

Bentham Science Publishers

Access to resources Recommend Favorite

Critical Limb Ischemia: Definition and Natural History

By  

Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 4, Iss. 3, 2004-09 ,pp. : 219-225

Bentham Science Publishers

Access to resources Recommend Favorite

Mesenchymal Stem Cells in Renal Ischemia-Reperfusion Injury: Biological and Therapeutic Perspectives

By  

Current Stem Cell Research & Therapy, Vol. 12, Iss. 3, 2017-02 ,pp. : 183-187

Bentham Science Publishers

Access to resources Recommend Favorite

Gene Therapy: A Battle Against Biological Barriers

By  

Current Molecular Medicine, Vol. 1, Iss. 4, 2001-09 ,pp. : 493-499

Bentham Science Publishers

Access to resources Recommend Favorite